Posted by Michael Wonder on 11 Dec 2017
New breast cancer drug approved for use in Scotland
11 December 2017 - A new breast cancer drug has been approved for use on the NHS in Scotland.
Palbociclib, which is taken in tablet form, can halt the spread of the disease in terminal patients for up to two years.
The move offers hope to women in advanced stages of breast cancer.
The SMC's approval of the drug is being described as a "wonderful decision" and "great news" for sufferers.
